Australia's largest stock trading and investment forum Australia's #1 stock forum

PER

0.00%

7.4¢ percheron therapeutics limited

Ann: New Indication for ATL1102 Limb Girdle Muscular Dystrophy R2, page-41

First 41 Last

Share
Profile

Follow
mephistophles

1,066 Posts.

498

21/06/22

22:21

Post #: 62124176
Share
Originally posted by SouvranStar: ↑

These lightbulbs (great analysis) give good information about how useful insights or DD a user is providing related to his overall count of posts...
only the last ones:

mephistophles: 877 posts and 310 lights
arjay: 2.385 posts and 538 lights
akki: 34.243 posts and 446 lights
vinceanna: 223 posts and 311 lights
itsagas: 10035 posts and 840 lights

i think these numbers are quite telling and esp. mephistophles and vinceanna i wouldnt count into the pumper-brigade. so before you start crying about telling the "truth" wont give lightbulbs, akki, maybe your narrative is to obvious and you need to ramp up your game

Expand

Hah! Where do I send the cheque Souv?

Originally posted by Vinceanna: ↑

If the EU DMD trial goes well (it's shown to be safe and effective), whether some LGMD patients might be able access ATL1102 early, outside of a trial setting ---- I assume we have an approved drug.- Safe and efficacy

Not sure the attached FDA document can provide some hints... just take a look and the scenario given.... and of course... This is only for our general knowledge!

https://www.fda.gov/patients/learn-about-expanded-access-and-other-treatment-options/understanding-unapproved-use-approved-drugs-label

Unapproved use of an approved drug is often called “off-label” use. This term can mean that the drug is:
Used for a disease or medical condition that it is not approved to treat, such as when a chemotherapy is approved to treat one type of cancer, but healthcare providers use it to treat a different type of cancer.
Given in a different way, such as when a drug is approved as a capsule, but it is given instead in an oral solution.
Given in a different dose, such as when a drug is approved at a dose of one tablet every day, but a patient is told by their healthcare provider to take two tablets every day.

If you and your healthcare provider decide to use an approved drug for an unapproved use to treat your disease or medical condition, remember that FDA has not determined that the drug is safe and effective for the unapproved use.

Questions you may want to consider:
Example:
What is the drug approved for?
What scientific studies are available to support the use of this drug to treat my disease or medical condition?
What are the potential benefits and risks of treating my disease or medical condition with this drug?
Are there any clinical trials studying the use of this drug for my disease or medical condition that I could enroll in..

From EMA: (I think they should have the same point of view as FDA??)
Definition of Off-label use ----Use of a medicine for an unapproved indication or in an unapproved age group, dosage, or route of administration.

Expand

Cheers for that, VA. I'm hoping to make time to read these:

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5086036/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630459/
ANP Price at posting: 9.2¢ Sentiment: Buy Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

Nine staff strike as Paris Olympic coverage begins

RHK

Red Hawk upgrades Blacksmith with DSO mineral resource at the Eagle Deposit

MND

Monadelphous inks $200M contract with Woodside to help build Pluto LNG – but will it make Scarborough cheaper?

IGO

IGO kicks off earn-in copper drilling on-site Encounter's Yeneena play as it adopts new identity

MIN

MinRes jumps 5% as the company meets production guidance – depressed iron ore prices be damned

There are more pages in this discussion • 46 more messages in this thread...

First 41 Last

Add PER (ASX) to my watchlist

(20min delay)
Last 7.4¢		Change 0.000(0.00%)		Mkt cap ! $66.71M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
2	6766	7.4¢

Sellers (Offers)

Price($)	Vol.	No.
7.7¢	146440	1

View Market Depth

No.	Vol.	Price($)
2	6766	0.074
2	142779	0.073
2	147362	0.072
2	310000	0.071
4	34299	0.070

Price($)	Vol.	No.
0.077	146440	1
0.078	156164	2
0.079	175123	2
0.080	337231	4
0.081	125000	2

Last trade - 10.06am 26/07/2024 (20 minute delay)

PER (ASX) Chart

Day chart unavailable

Ann: New Indication for ATL1102 Limb Girdle Muscular Dystrophy R2, page-41

Nine staff strike as Paris Olympic coverage begins

Red Hawk upgrades Blacksmith with DSO mineral resource at the Eagle Deposit

Monadelphous inks $200M contract with Woodside to help build Pluto LNG – but will it make Scarborough cheaper?

IGO kicks off earn-in copper drilling on-site Encounter's Yeneena play as it adopts new identity

MinRes jumps 5% as the company meets production guidance – depressed iron ore prices be damned

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: New Indication for ATL1102 Limb Girdle Muscular Dystrophy R2, page-41

Top Stories

Nine staff strike as Paris Olympic coverage begins

Red Hawk upgrades Blacksmith with DSO mineral resource at the Eagle Deposit

Monadelphous inks $200M contract with Woodside to help build Pluto LNG – but will it make Scarborough cheaper?

IGO kicks off earn-in copper drilling on-site Encounter's Yeneena play as it adopts new identity

MinRes jumps 5% as the company meets production guidance – depressed iron ore prices be damned

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News